Post-Treatment Transition Can Be Scary for Cancer Survivors
Post-Treatment Transition Can Be Scary for Cancer Survivors
D McNamara
20090303
2009 Apr 3
Elsevier Global Medical News
Post-Treatment Transition Can Be Scary for Cancer Survivors
Elsevier Global Medical News. 2009 Apr 3, D McNamara
Many people experience fear, anxiety, and depression during the transition from cancer patient to survivor.
Advisory and Editorial Boards
Meet OncologySTAT's Advisory and Editorial Boards that represent community practitioners and academic specialists with cross-disciplinary expertise.Editors' Choice
Neoadjuvant Trastuzumab improves event-free survival in HER2+ locally advanced or inflammatory breast cancer.
